Best Tesamorelin Telehealth Providers for Muscle growth and athletic performance
An FDA-approved growth hormone-releasing factor analog originally indicated for HIV-associated lipodystrophy. Increasingly used off-label for body composition optimization and visceral fat reduction.
Reviewed by Dr. James Okafor, PharmDPharmDWhat is Tesamorelin Used For?
- ✓Visceral fat reduction
- ✓Growth hormone stimulation
- ✓Body composition
- ✓Metabolic health
How Tesamorelin Works
Tesamorelin is a GHRH analog — a synthetic version of growth hormone-releasing hormone — that stimulates pituitary GH secretion. Unlike sermorelin (which covers the first 29 amino acids of GHRH), tesamorelin covers the full 44-amino-acid sequence conjugated to a trans-2-hexenoic acid moiety for stability. It is FDA-approved (Egrifta) for HIV-associated lipodystrophy and demonstrates particularly potent visceral fat reduction through GH-mediated lipolysis in abdominal adipose tissue.
What to Expect
The FDA approval for HIV lipodystrophy is based on studies showing 15–20% reduction in visceral adipose tissue (VAT) over 26 weeks. Off-label use for body recomposition shows meaningful visceral fat reduction at 3–6 months. GH and IGF-1 levels typically rise 30–50% within the first 4 weeks. Many users also report improvements in energy, sleep, and muscle tone.
Common Side Effects
- ⚠Injection site reactions (common — redness, bruising, pain)
- ⚠Peripheral edema (water retention)
- ⚠Arthralgia (joint pain)
- ⚠Carpal tunnel syndrome symptoms
- ⚠Flushing
- ⚠Blood glucose elevation (monitor in pre-diabetic patients)
This is not a complete list of side effects. Always consult your prescribing physician before starting Tesamorelin.
Frequently Asked Questions About Tesamorelin
Is tesamorelin FDA-approved for weight loss?▾
Tesamorelin (Egrifta) is FDA-approved specifically for visceral adiposity in HIV-infected adults with lipodystrophy — not for general obesity. Off-label use for body recomposition and visceral fat reduction in non-HIV patients is common in anti-aging and hormone optimization medicine.
How does tesamorelin compare to sermorelin?▾
Both are GHRH analogs, but tesamorelin covers the full 44-amino-acid sequence and has a longer half-life (thanks to its trans-2-hexenoic acid modification). Clinical evidence shows tesamorelin produces stronger GH stimulation and more pronounced visceral fat reduction than sermorelin. It is typically the preferred choice when visceral fat is the primary treatment target.
Can tesamorelin be used long-term?▾
The FDA approval is based on 26-week and 52-week trials. Long-term use (beyond 52 weeks) requires ongoing monitoring of blood glucose and IGF-1 levels. When tesamorelin is discontinued, visceral fat typically returns over time — suggesting it may need to be a long-term intervention for sustained results.
Who is the ideal candidate for tesamorelin?▾
Ideal candidates are adults with excess visceral fat, suboptimal GH/IGF-1 levels (common in aging), and metabolic syndrome features. It is particularly suited to patients whose primary goal is visceral fat reduction rather than muscle growth — for whom it outperforms most other GHRH analogs.
4 Providers Offering Tesamorelin
Sorted by lowest price first.
| Provider | Price | Dose | Rating | Consultation | Lab Testing |
|---|---|---|---|---|---|
| Hone Health Pittsburgh, PA | $349/monthly | 2mg/day | 4/5 | Async Telehealth | Included |
| Defy Medical Tampa, FL | $350/monthly | 2mg/day | 4.1/5 | Video Telehealth | Included |
| Evolve Telemed San Diego, CA | $380/monthly | 2mg/day | 4/5 | Video Telehealth | Included |
| TruLife Health Scottsdale, AZ | $420/monthly | 2mg/day | 4.1/5 | Video Telehealth | Included |